SEED Co.,Ltd.

7743.T
Medical Instruments & Supplies
2026/08/25 Updated
Market Cap: $102.6M (¥16.3B)
Stock Price: $3.39 (¥540)
Exchange Rate: 1 USD = ¥159.24

Q1 Fiscal Year Ending March 2027 Consolidated Earnings Briefing

Consolidated earnings summary for the first quarter of the fiscal year ending March 2027. Net sales of 8,848 million yen (YoY +3.5%), operating income of 618 million yen (YoY -2.0%). Gross profit was 4,151 million yen, YoY +7.9%, but selling, general and administrative expenses rose due to increases in R&D and personnel costs, resulting in lower operating income. Growth contributed by AirGrade expansion and overseas sales growth in China cross-border e-commerce. Progress on the medium-term plan and future growth strategy disclosed.

Importance:
Page Updated: August 25, 2026
IR Disclosure Date: August 25, 2026

Key Figures

  • Net sales: 8,848百万円(YoY +3.5%)
  • Gross profit: 4,151百万円(YoY +7.9%)
  • Operating income: 618百万円(YoY △2.0%)

AI要約

Section Heading

Key earnings points show revenue growth offset by higher SG&A costs, leading to a decrease in operating income. By segment, growth contributed by the 1day contact lens series for astigmatism and multifocal lenses, and expansion of the AirGrade series. Overseas sales expanded against the background of China cross-border e-commerce growth. Depreciation related to the fourth building is progressing.

Section 2 Heading

Progress of the medium-term management plan and future growth strategy are described, with consideration of contributions toward the full-year outlook for the fiscal year ending March 2027. In particular, focus is on branding the domestically produced 1day Pure series, expanding the Chinese market, and strengthening promotions in Southeast Asia to build a foundation for long-term growth.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Seed Corporation

Company overview · Stock price · Financial data · All IR

View company page →